Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer

Title
Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
Authors
Keywords
Abiraterone, Antihormonal drugs, Castration-resistant prostate cancer, Chemotherapy, Docetaxel, Enzalutamide, Metastatic, Oncology, Taxane
Journal
ADVANCES IN THERAPY
Volume 31, Issue 2, Pages 234-241
Publisher
Springer Nature
Online
2014-01-17
DOI
10.1007/s12325-014-0092-1

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now